Medline Inc.
L10
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/28/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.48% | -1.68% | 0.00% | 13.32% | -10.80% |
| Total Depreciation and Amortization | 3.16% | 1.81% | 0.00% | -1.78% | 2.02% |
| Total Amortization of Deferred Charges | -6.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 20.00% | -54.77% | 0.00% | 99.00% | -31.51% |
| Change in Net Operating Assets | -28,300.00% | 100.40% | 0.00% | 63.09% | -1,196.77% |
| Cash from Operations | -63.99% | 44.71% | 0.00% | 702.05% | -110.11% |
| Capital Expenditure | -36.63% | 16.18% | 0.00% | -32.42% | 14.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.00% | 0.00% | 150.00% | 99.33% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -36.63% | 14.04% | 0.00% | -21.13% | 90.28% |
| Total Debt Issued | -100.00% | 8,356.98% | 0.00% | -98.58% | 188.39% |
| Total Debt Repaid | 46.20% | -7,569.70% | 0.00% | 98.43% | -134.68% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -10,844.44% | -140.00% | 0.00% | -650.00% | 66.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 19.33% | 21.45% | 0.00% | 88.85% | -3,135.71% |
| Other Financing Activities | -- | -- | -- | -- | -166.67% |
| Cash from Financing | 657.14% | 4.45% | 0.00% | 87.91% | -149.82% |
| Foreign Exchange rate Adjustments | 66.67% | -122.22% | 0.00% | 775.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.04% | 122.16% | 0.00% | 110.66% | -87.32% |